HomeMRNS • NASDAQ
add
Marinus Pharmaceuticals Inc
Previous close
$0.30
Day range
$0.30 - $0.32
Year range
$0.26 - $11.26
Market cap
17.07M USD
Avg Volume
4.58M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Revenue | 8.54M | 16.39% |
Operating expense | 28.91M | 94.42% |
Net income | -24.22M | 26.53% |
Net profit margin | -283.63 | 36.88% |
Earnings per share | -0.42 | 31.15% |
EBITDA | -19.90M | 33.67% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 42.18M | -76.08% |
Total assets | 63.62M | -68.32% |
Total liabilities | 130.36M | -10.87% |
Total equity | -66.74M | — |
Shares outstanding | 57.23M | — |
Price to book | -0.26 | — |
Return on assets | -69.94% | — |
Return on capital | -176.96% | — |
Cash Flow
Net change in cash
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Net income | -24.22M | 26.53% |
Cash from operations | — | — |
Cash from investing | — | — |
Cash from financing | — | — |
Net change in cash | — | — |
Free cash flow | — | — |
About
Founded
2003
Headquarters
Website
Employees
166
